By Aduragbemi Omiyale GlaxoSmithKline Consumer Nigeria (GSK) Plc has commenced the payment of the approved N17.42 per share to minority shareholders as part of
By Dipo Olowookere The Securities and Exchange Commission (SEC) has granted the request of GlaxoSmithKline (GSK) Consumer Nigeria Plc to leave the Nigerian Exchange
By Aduragbemi Omiyale A British pharmaceutical company, GlaxoSmithKline (GSK) UK Group, intends to close its operations in Nigeria and then exit the Nigerian Exchange